Dainippon Sumitomo agrees transfer of Japan growth hormone business
This article was originally published in Scrip
Executive Summary
Dainippon Sumitomo Pharma (DSP) has finalised an agreement to transfer its domestic human growth hormone business to fellow Japanese firm JCR Pharmaceuticals.